[治疗精神分裂症的新精神药理学选择]。

Swiss Archives of Neurology and Psychiatry Pub Date : 1994-01-01

C Bryois

{"title":"[治疗精神分裂症的新精神药理学选择]。","authors":"C Bryois","doi":"","DOIUrl":null,"url":null,"abstract":"Clozapine, risperidone and remoxipride are three neuroleptics that represent an interesting alternative in the psychopharmacological treatment of schizophrenia. Pharmacodynamic and pharmacokinetic properties, efficacy, dosages as well as the indication of these three substances are studied. In certain particular situations, a complementary treatment is of important therapeutic use, the addition of benzodiazepines, lithium, carbamazepine or beta-blockers are discussed.","PeriodicalId":30134,"journal":{"name":"Swiss Archives of Neurology and Psychiatry","volume":"145 6","pages":"19-24"},"PeriodicalIF":0.0000,"publicationDate":"1994-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[New psychopharmacologic alternatives in treatment of schizophrenia].\",\"authors\":\"C Bryois\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clozapine, risperidone and remoxipride are three neuroleptics that represent an interesting alternative in the psychopharmacological treatment of schizophrenia. Pharmacodynamic and pharmacokinetic properties, efficacy, dosages as well as the indication of these three substances are studied. In certain particular situations, a complementary treatment is of important therapeutic use, the addition of benzodiazepines, lithium, carbamazepine or beta-blockers are discussed.\",\"PeriodicalId\":30134,\"journal\":{\"name\":\"Swiss Archives of Neurology and Psychiatry\",\"volume\":\"145 6\",\"pages\":\"19-24\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Swiss Archives of Neurology and Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Swiss Archives of Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

氯氮平、利培酮和莫西普利是三种神经抑制剂，在精神分裂症的精神药理学治疗中代表了一种有趣的选择。对这三种物质的药效学和药动学性质、疗效、剂量及适应症进行了研究。在某些特殊情况下，辅助治疗具有重要的治疗用途，讨论了苯二氮卓类药物，锂，卡马西平或-受体阻滞剂的添加。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[New psychopharmacologic alternatives in treatment of schizophrenia].

Clozapine, risperidone and remoxipride are three neuroleptics that represent an interesting alternative in the psychopharmacological treatment of schizophrenia. Pharmacodynamic and pharmacokinetic properties, efficacy, dosages as well as the indication of these three substances are studied. In certain particular situations, a complementary treatment is of important therapeutic use, the addition of benzodiazepines, lithium, carbamazepine or beta-blockers are discussed.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Swiss Archives of Neurology and Psychiatry

自引率

0.00%

发文量

审稿时长

16 weeks

期刊介绍： Schweizer Archiv für Neurologie und Psychiatrie Archives suisses de neu-rologie et de psychiatrie Swiss Archives of Neurology and Psychiatry Official publication of the Swiss Neurological Society and official scientific publication of the Swiss Society of Psychiatry and Psychotherapy and the Swiss Society for Child and Adolescent Psychiatry and Psychotherapy